InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by WEISS MICHAEL S, Chief Executive Officer. Insider active across 4 companies, notably Checkpoint Therapeutics, Inc.. In total, 10 reports have been published. The latest transaction was filed on 16 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
047,619 shares0
COMMON STOCK
SEC:0001104659-22-074464:0·
01,102,986 shares0
Common Stock
SEC:0001104659-22-053619:0·
03,000 shares0
COMMON STOCK
SEC:0001104659-22-002355·
03,000 shares0
COMMON STOCK
SEC:0001104659-22-002355:0·
013,774 shares0
COMMON STOCK
SEC:0001104659-21-090246·
013,774 shares0
COMMON STOCK
SEC:0001104659-21-090246:0·
01,080,770 shares0
COMMON STOCK
SEC:0001104659-21-084261·
01,080,770 shares0
COMMON STOCK
SEC:0001104659-21-084261:0·
016,502 shares0
COMMON STOCK
SEC:0001104659-21-080364:0·
016,502 shares0
COMMON STOCK
SEC:0001104659-21-080364·
10 of 10 declarations
About WEISS MICHAEL S
Michael S. Weiss is the CEO and President at Checkpoint Therapeutics, Inc., TG THERAPEUTICS, INC., and MUSTANG BIO, INC. He has extensive experience in business management and strategic development. Michael is responsible for the overall direction of the companies and the execution of their business strategy.
